Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 30Terminated 10Active not recruiting 6Withdrawn 5Unknown 5Recruiting 3

Sponsor Class

OTHER 163INDUSTRY 69OTHER_GOV 6NIH 3NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 1Pancreatic Neoplasms 1Adenoma, Islet Cell 1

Interventions

Specimen Handling 39Magnetic Resonance Spectroscopy 30Carboplatin 14Biopsy 14Radiation 13Cyclophosphamide 13Radiotherapy 11daratumumab 10Vincristine 10Dexamethasone 10Surgical Procedures, Operative 9Etoposide 9Lenalidomide 8X-Rays 7Observation 7Leucovorin 7Irinotecan 7Doxorubicin 7Cisplatin 7durvalumab 6dexamethasone acetate 6dexamethasone 21-phosphate 6auricularum 6Watchful Waiting 6Radiosurgery 6Docetaxel 6Calcium Dobesilate 6pembrolizumab 5Stem Cell Transplantation 5Standard of Care 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × NETWORK × Capecitabine × Clear all
NCT06205485 2026-05-12

NEO-RT

Canadian Cancer Trials Group

Phase 3 Recruiting
250 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05040360 2025-12-15

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

SWOG Cancer Research Network

Phase 2 Recruiting
141 enrolled

Adenoma, Islet Cell

NCT02598349 2025-09-09

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Proton Collaborative Group

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡